Intervention not reported
Asthma symptoms measured using various techniques. · patients with asthma aged eight years or older
1 finding from 1 review
Intervention not reported
Quality of life Measured using various scales. · patients with asthma aged eight years or older
1 finding from 1 review
Intervention not reported
Exercise tolerance Measured using 6MWD · patients with asthma aged eight years or older
1 finding from 1 review
Intervention not reported
PEFR L/min · patients with asthma aged eight years or older
1 finding from 1 review
Intervention not reported
VEmax · patients with asthma aged eight years or older
1 finding from 1 review
Intervention not reported
VOmax · patients with asthma aged eight years or older
1 finding from 1 review
Intervention not reported
HRmax bpm · patients with asthma aged eight years or older
1 finding from 1 review
Change in Morning PEF after 12 months (% predicted) · asthmatics with sensitivity to house dust mite
MHRV showed no clear difference in change in Morning PEF after 12 months (% predicted) compared with placebo (moderate certainty).
1 finding from 1 review
Change in Evening PEF after 12 months (% predicted) · asthmatics with sensitivity to house dust mite
MHRV probably leads to higher change in Evening PEF after 12 months (% predicted) compared with placebo (moderate certainty).
1 finding from 1 review
FEV1 · asthmatics with sensitivity to house dust mite
MHRV showed no clear difference in change in FEV1 after 12 months (% predicted) compared with placebo (moderate certainty).
1 finding from 1 review
SGRQ Total SGRQ (Total) Score. Scale from: 0 to 100. Lower score indicates better quality of life. · asthmatics with sensitivity to house dust mite
MHRV showed no clear difference in quality of life SGRQ Scale from 0 to 100 (0 on the scale is better) compared with placebo (moderate certainty).
1 finding from 1 review
Mean exacerbations requiring a course of oral corticosteroids · asthmatics with sensitivity to house dust mite
MHRV showed no clear difference in exacerbations needing oral steroids compared with placebo (moderate certainty).
1 finding from 1 review
Exacerbations leading to ED visits · asthmatics with sensitivity to house dust mite
MHRV showed no clear difference in exacerbations needing ED visit compared with placebo (moderate certainty).
1 finding from 1 review
Exacerbations needing hospitalisation · asthmatics with sensitivity to house dust mite
MHRV showed no clear difference in exacerbations needing hospitalisation compared with placebo (moderate certainty).
1 finding from 1 review
Maximal percentage fall in FEV1 · exercise‐induced asthma
1 finding from 1 review
Number of participants with an FEV1 fall > 10% · exercise‐induced asthma
Beta2‐agonists probably leads to lower number of participants with an FEV1 fall > 10% compared with placebo (single administration) (moderate certainty).
1 finding from 1 review
Maximal percentage fall in PEF · exercise‐induced asthma
1 finding from 1 review
Maximal percentage fall in FEF25‐75% · exercise‐induced asthma
1 finding from 1 review
Side effects · exercise‐induced asthma
Beta2‐agonists showed no clear difference in side effects compared with placebo (single administration) (low certainty).
1 finding from 1 review
Inspiratory muscle strength · people with asthma
1 finding from 1 review